<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1052243361488264&amp;ev=PageView&amp;noscript=1">

Did You Miss Us At AACR 2016?

We recently presented a scientific poster at AACR 2016 in New Orleans. This study highlights the value of flow cytometry as a single platform for evaluating primary mechanisms of action, such as ADCP, ADCC, CDC, Apoptosis and Trogocytosis, of therapeutic antibodies during drug discovery.

Please reach out to us at contact@flowmetric.com if you have any questions or wish to use any of these mechanistic assays in your upcoming studies!Flow Cytometry as a Single Platform Tool to Evaluate Multiple Mechanisms of Action of Therapeutic Antibodies

Complete This Form To Download The Poster